- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02944877
HOPE Social Media Intervention for HIV Testing and Studying Social Networks
October 3, 2024 updated by: Sean D Young, University of California, Irvine
This study [HOPE: Harnessing Online Peer Education] seeks to determine the efficacy of using online social networks to scale peer community leader models to increase HIV prevention within African-American and Latino men who have sex with men.
The peer community leader model, which teaches community popular opinion leaders about how to disseminate behavior changes messages throughout the community, has been proven to increase HIV prevention behaviors.
Social media and online communities, such as Facebook, may be a cost-effective platform for scaling these models.
Primarily upper middle-class White populations used the Internet in its early years, however, Internet use within African-American and Latino households has recently increased dramatically, especially on social media.
People using the Internet may be at the highest risk for contracting HIV and are using novel Internet approaches to find sex partners, such as through social media.
This is the first study to examine the effectiveness of the HOPE social media intervention to increase HIV testing among at-risk groups in the United States.
Study Overview
Study Type
Interventional
Enrollment (Actual)
900
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Irvine, California, United States, 92697
- University of California Irvine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 89 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18 years of age or older
- Male
- Sexually active with another man in the last 12 months
- Willing and capable of understanding and assenting to an online informed consent form
- Has (or willing to create) a social media page.
Exclusion Criteria:
- Does not satisfy inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention
experimental
|
social media intervention
|
|
Other: control
Other
|
social media intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Requesting HIV Self-Testing
Time Frame: 5 years
|
At home/self HIV testing kits can be requested to be ordered and will be provided to all participants who request it.
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sean Young, University of California, Irvine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2016
Primary Completion (Actual)
January 31, 2021
Study Completion (Actual)
January 31, 2023
Study Registration Dates
First Submitted
February 5, 2016
First Submitted That Met QC Criteria
October 25, 2016
First Posted (Estimated)
October 26, 2016
Study Record Updates
Last Update Posted (Actual)
October 29, 2024
Last Update Submitted That Met QC Criteria
October 3, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 20205768
- 1R01MH106415 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.